We propose a novel process where singly charged Higgs bosons are produced in a same-sign pair via vector boson fusion at hadron colliders in two Higgs doublet models. The process directly relates to the global symmetry structure of the Higgs potential. The produced charged Higgs bosons predominantly decay into a tau lepton and the neutrino or into a pair of top and bottom quarks, depending on the type of Yukawa interactions. We evaluate the signal and the background for the both cases at the CERN Large Hadron Collider and future higher-energy hadron colliders. We find that the process can be feasible and useful to explore the nature of the Higgs potential.
We investigate a new scenario of the two Higgs doublet model, where the current experimental data for the electroweak rho parameter and those for the Higgs boson couplings can be simultaneously explained. In this scenario, the two Higgs doublet model is supposed to be a low energy effective theory up to a high energy scale Λ, above which a fundamental theory should appear. It is assumed that the Higgs potential respects a global symmetry at Λ (the twisted custodial symmetry), which is to be given as a consequence of the global symmetry structure of the fundamental theory above Λ. By the analysis using one-loop renormalization group equations, the above experimental data can be explained in a natural way even when the masses of the extra Higgs bosons are near the electroweak scale. We also discuss the predictions on the mass spectrum of the additional Higgs bosons and also those on the coupling constants of the standard-model-like Higgs boson, which make it possible to test this scenario at the current and future collider experiments.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.